BACKGROUND: Neutrophil dysfunction plays an important role in inflammation-induced tissue injury. Previously, we identified protein kinase C-δ (PKCδ) as a critical controller of neutrophil activation and trafficking but how PKCδ is regulated in inflammation has not been delineated. PKCδ activity is regulated by tyrosine phosphorylation on multiple sites. Tyrosine155 is a key regulator of apoptosis and gene expression, but its role in proinflammatory signaling is not known. METHODS: In-vitro studies - superoxide anion (O2) and neutrophil extracellular traps (NETs) were measured in bone marrow neutrophils (BMN) isolated from wild type (WT) and PKCδY155F knock-in mice (PKCδ tyrosine 155 → phenylalanine). Our novel 3D biomimetic microfluidic assay (bMFA) was used to delineate PKCδ-mediated regulation of individual steps in neutrophil adhesion and migration using WT and PKCδY155F BMN and mouse lung microvascular endothelial cells (MLMVEC). In-vivo studies - WT and PKCδY155F knock-in mice underwent sham or cecal ligation and puncture surgery and the lungs harvested 24 h post-surgery. RESULTS: In vitro - PKCδY155F BMN had significantly reduced O2 and NETs release compared with WT. WT BMN, but not PKCδY155F BMN, demonstrated significant adhesion and migration across tumor necrosis factor-activated MLMVEC in bMFA. PKCδ inhibition significantly reduced WT BMN adhesion and migration under low shear and near bifurcations, but had no effect on PKCδY155F BMN. In vivo - mutation of PKCδ tyrosine 155 significantly decreased neutrophil migration into the lungs of septic mice. CONCLUSIONS: PKCδ tyrosine 155 is a key phosphorylation site controlling proinflammatory signaling and neutrophil-endothelial cell interactions. These studies provide mechanistic insights into PKCδ regulation during inflammation.
BACKGROUND:Neutrophil dysfunction plays an important role in inflammation-induced tissue injury. Previously, we identified protein kinase C-δ (PKCδ) as a critical controller of neutrophil activation and trafficking but how PKCδ is regulated in inflammation has not been delineated. PKCδ activity is regulated by tyrosine phosphorylation on multiple sites. Tyrosine155 is a key regulator of apoptosis and gene expression, but its role in proinflammatory signaling is not known. METHODS: In-vitro studies - superoxide anion (O2) and neutrophil extracellular traps (NETs) were measured in bone marrow neutrophils (BMN) isolated from wild type (WT) and PKCδY155F knock-in mice (PKCδ tyrosine 155 → phenylalanine). Our novel 3D biomimetic microfluidic assay (bMFA) was used to delineate PKCδ-mediated regulation of individual steps in neutrophil adhesion and migration using WT and PKCδY155F BMN and mouse lung microvascular endothelial cells (MLMVEC). In-vivo studies - WT and PKCδY155F knock-in mice underwent sham or cecal ligation and puncture surgery and the lungs harvested 24 h post-surgery. RESULTS: In vitro - PKCδY155F BMN had significantly reduced O2 and NETs release compared with WT. WT BMN, but not PKCδY155F BMN, demonstrated significant adhesion and migration across tumor necrosis factor-activated MLMVEC in bMFA. PKCδ inhibition significantly reduced WT BMN adhesion and migration under low shear and near bifurcations, but had no effect on PKCδY155F BMN. In vivo - mutation of PKCδ tyrosine 155 significantly decreased neutrophil migration into the lungs of septic mice. CONCLUSIONS:PKCδ tyrosine 155 is a key phosphorylation site controlling proinflammatory signaling and neutrophil-endothelial cell interactions. These studies provide mechanistic insights into PKCδ regulation during inflammation.
Authors: Fariborz Soroush; Yuan Tang; Hasan M Zaidi; Joel B Sheffield; Laurie E Kilpatrick; Mohammad F Kiani Journal: FASEB J Date: 2018-06-13 Impact factor: 5.191
Authors: L Chen; H Hahn; G Wu; C H Chen; T Liron; D Schechtman; G Cavallaro; L Banci; Y Guo; R Bolli; G W Dorn; D Mochly-Rosen Journal: Proc Natl Acad Sci U S A Date: 2001-09-11 Impact factor: 11.205
Authors: Wen-Hai Chou; Doo-Sup Choi; Hong Zhang; Dezhi Mu; Tom McMahon; Viktor N Kharazia; Clifford A Lowell; Donna M Ferriero; Robert O Messing Journal: J Clin Invest Date: 2004-07 Impact factor: 14.808
Authors: Kristen Page; Jing Li; Limei Zhou; Svetlana Iasvovskaia; Kevin C Corbit; Jae-Won Soh; I Bernard Weinstein; Allan R Brasier; Anning Lin; Marc B Hershenson; Svetlana Iasvoyskaia Journal: J Immunol Date: 2003-06-01 Impact factor: 5.422
Authors: Mark J Mondrinos; Linda C Knight; Paul A Kennedy; Jichuan Wu; Matthew Kauffman; Sandy T Baker; Marla R Wolfson; Laurie E Kilpatrick Journal: J Pharmacol Exp Ther Date: 2015-08-04 Impact factor: 4.030
Authors: Elisabetta Liverani; Sarah A Tursi; William D Cornwell; Mark J Mondrinos; Shuang Sun; Bettina A Buttaro; Marla R Wolfson; Thomas J Rogers; Çagla Tükel; Laurie E Kilpatrick Journal: FASEB J Date: 2019-12-23 Impact factor: 5.191
Authors: Qingliang Yang; Jordan C Langston; Yuan Tang; Mohammad F Kiani; Laurie E Kilpatrick Journal: Int J Mol Sci Date: 2019-03-26 Impact factor: 5.923
Authors: R Paul Wilson; Sarah A Tursi; Glenn J Rapsinski; Nicole J Medeiros; Long S Le; Kevin P Kotredes; Sajan Patel; Elisabetta Liverani; Shuang Sun; Wenhan Zhu; Laurie Kilpatrick; Sebastian E Winter; Ana M Gamero; Çagla Tükel Journal: PLoS Pathog Date: 2019-04-22 Impact factor: 6.823
Authors: Qingliang Yang; Harshani Wijerathne; Jordan C Langston; Mohammad F Kiani; Laurie E Kilpatrick Journal: Int J Mol Sci Date: 2021-07-21 Impact factor: 5.923